Due	IN	_
to	IN	_
its	PRP$	_
action	NN	_
on	IN	_
both	CC	_
the	DT	_
serotoninergic	JJ	_
and	CC	_
adrenergic	JJ	_
systems	NNS	_
,	,	_
Venlafaxine	NNP	_
is	VBZ	_
also	RB	_
used	VBN	_
as	IN	_
a	DT	_
treatment	NN	_
to	TO	_
reduce	VB	_
episodes	NNS	_
of	IN	_
cataplexy	NN	_
,	,	_
a	DT	_
form	NN	_
of	IN	_
muscle	NN	_
weakness	NN	_
,	,	_
in	IN	_
patients	NNS	_
with	IN	_
the	DT	_
sleep	NN	_
disorder	NN	_
narcolepsy	NN	_
.	.	_

